top of page

To help us continue to support HS warriors, click here:

CLINICAL TRIAL OPPORTUNITES

"PARTICIPATE LIKE THE FUTURE OF HS DEPENDS ON IT, BECAUSE IT DOES."

ONLINE
SURVEYS
& STUDIES

SALE (2).png

OPEN
CLINICAL
TRIALS

SALE (1).png

These clinical trials and studies are the newest and most exciting opportunities for you to be a part of changing the future of HS for the whole community!

ATTENTION Researchers, Physicians, Pharmaceutical Reps or Sponsors
If you're interested in listing your clinical trial, study or survey with us, please consult with us prior to requesting IRB approval in order to get the best results. Contact us here.

*Clinical trials, research and surveys are open until the quota of participants is met or the study is concluded. We are consistently checking and updating this page. If you come across a study that is closed or no longer accepting participants, please let us know here.*

Hot New Adds

HOT NEW ADDS!!

Sanofi Clinical Trial

AGE: 18-70

HURLEY STAGE: II & III

LOCATION: US Only

Eltrekibart Clinical Trial

AGE: 18-75

HURLEY STAGE: II & III

LOCATION: US Only

HS Interview Study

AGE: 12 - 70

HURLEY STAGE: II & III

LOCATION: US Only

Surveys/Studies

ONLINE SURVEYS / STUDIES

RARE PATIENT VOICES (Instagram Post) (12 × 3 in) (2).png

HS Connect Survey

AGE: Any Age

HURLEY STAGE: All

LOCATION: All

Novartis Pharmaceuticals

AGE: 18+

SEVERITY: Moderate to Severe

LOCATION: Germany

Post Secukinumab Initiation Study

AGE: 18+

HURLEY STAGE: All

LOCATION: France

Novartis Pharmaceuticals Study

AGE: 18+

SEVERITY: Moderate to Severe

LOCATION: Russia

HS Genetic Traits Study

AGE: 7+

HURLEY STAGE: All

LOCATION: US

HS Interview Study

AGE: 12 - 70

HURLEY STAGE II & III

LOCATION: US

CLINICAL TRIAL OPPORTUNITIES

Clinical Trial Opportunities

Spesolimab Clinical Trial

AGE: 18+

HURLEY STAGE: All

LOCATION: International

Povorcitinib Clinical Trial (STOP-HS LTE)

AGE: 18+

HURLEY STAGE: All

LOCATION: International

Physical Activity Trial

AGE: 18-80

SEVERITY: Moderate to Severe

LOCATION: US Only

A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients with Moderate to Severe Hidradenitis Suppurativa

AGE: 18+

HURLEY STAGE: II & III

LOCATION: US Only

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

AGE: 18+

HURLEY STAGE: All

LOCATION: US Only

Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

AGE: 18+

HURLEY STAGE: All

LOCATION: US Only

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

AGE: 18+

SEVERITY: Moderate to Severe

LOCATION: International

Clinical and Biological Characteristics of Hidradenitis Suppurativa

AGE: 13+

HURLEY STAGE: All

LOCATION: US Only

Povorcitinib Clinical Trial (STOP-HS2)

AGE: 18+

HURLEY STAGE: II & III

LOCATION: International

Deucravacitinib Clinical Trial

AGE: 18-70

HURLEY STAGE: All

LOCATION: US Only

HS Mindfulness Training Trial

AGE: 18+

HURLEY STAGE: All

LOCATION: US Only

Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

AGE: 18+

HURLEY STAGE: All

LOCATION: International

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa

AGE: 18-70

HURLEY STAGE: II & III

LOCATION: US Only

Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

AGE: 18+

HURLEY STAGE: II & III

LOCATION: US Only

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

AGE: 18+

SEVERITY: Moderate to Severe

LOCATION: International

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

AGES: 10+

HURLEY STAGE: All

LOCATION: US Only

Povorcitinib Clinical Trial (STOP-HS1)

AGE: 18+

HURLEY STAGE: II & III

LOCATION: International

Anifrolumab Clinical Trial

AGE: 18+

HURLEY STAGE: All

LOCATION: US Only

AbbVie Clinical Trail

AGE: 12+

HURLEY STAGE: II & III

LOCATION: International

Hidradenitis - an Analysis of Genetic Traits and Linkages in Families

AGE: 7+

HURLEY STAGE: All

LOCATION: US Only

Regulation of Inflammatory Genes in Hidradenitis Suppurativa

AGE: 18+

HURLEY STAGE: All

LOCATION: US Only

A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

AGE: 18+

HURLEY STAGE: II & III

LOCATION: US Only

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

AGE: 18-70

HURLEY STAGE: II & III

LOCATION: US Only

Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

AGE: 12+

HURLEY STAGE: I & II

LOCATION: US Only

bottom of page